Resumen
A series of N-substituted lobelane analogues was synthesized and evaluated for their [3H]dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [ 3H]dopamine uptake. Compound 19a, which contains an N-1,2(R)-dihydroxypropyl group, had been identified as a potential clinical candidate for the treatment of methamphetamine abuse.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 564-568 |
| Número de páginas | 5 |
| Publicación | MedChemComm |
| Volumen | 4 |
| N.º | 3 |
| DOI | |
| Estado | Published - mar 2013 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry